Your browser doesn't support javascript.
loading
Prognosis and Personalized Treatment Prediction in Different Mutation-Signature Hepatocellular Carcinoma.
Zhang, Yuyuan; Liu, Zaoqu; Li, Jie; Li, Xin; Duo, Mengjie; Weng, Siyuan; Lv, Peijie; Jiang, Guozhong; Wang, Caihong; Li, Yan; Liu, Shichao; Li, Zhen.
Afiliación
  • Zhang Y; Department of Interventional Radiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, People's Republic of China.
  • Liu Z; Department of Interventional Radiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, People's Republic of China.
  • Li J; Department of Interventional Radiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, People's Republic of China.
  • Li X; Department of Interventional Radiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, People's Republic of China.
  • Duo M; Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, People's Republic of China.
  • Weng S; Department of Interventional Radiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, People's Republic of China.
  • Lv P; Department of Radiology, Zhengzhou University First Affiliated Hospital, Zhengzhou, Henan, People's Republic of China.
  • Jiang G; Department of Pathology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, People's Republic of China.
  • Wang C; Department of Magnetic Resonance Imaging, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, People's Republic of China.
  • Li Y; Department Cardiology, The Second Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, People's Republic of China.
  • Liu S; Department Cardiology, The Second Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, People's Republic of China.
  • Li Z; Department of Interventional Radiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, People's Republic of China.
J Hepatocell Carcinoma ; 10: 241-255, 2023.
Article en En | MEDLINE | ID: mdl-36815095
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: J Hepatocell Carcinoma Año: 2023 Tipo del documento: Article Pais de publicación: Nueva Zelanda
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: J Hepatocell Carcinoma Año: 2023 Tipo del documento: Article Pais de publicación: Nueva Zelanda